GSK
Pharma

GSK pledges $800M to upgrade its R&D, manufacturing in PA

GSK is plugging more than $800 million into an overhaul of its facilities in Upper Merion Township, where construction is slated to kick off in 2027.
Fraiser Kansteiner Oct 9, 2026 4:13pm
For biopharma manufacturing at speed and scale the future is flexible

For biopharma manufacturing at speed and scale, the future is flexible

Brought to you by Resilience
Magnifying glass with pills on blue

Regulatory tracker: Tecentriq cleared in colon cancer

Oct 9, 2026 2:30pm
Advancing Treatment A Closer Look at ADT Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Prescriptions edge down

Oct 9, 2026 1:48pm
paper paperclips

FDA’s Rasonque review documents pressure RevMed

Oct 9, 2026 11:25am
More News
Fierce Healthcare

Hospital industry takes HHS to court in 340B rebate rematch

Oct 9, 2026 11:20am

Quince, now IRulya, debuts new name, focus and leadership

Oct 9, 2026 11:05am

Teva bags long-sought reformulated olanzapine schizophrenia nod

Oct 9, 2026 9:56am

Novartis, Shionogi, ArriVent—Fierce Pharma Asia

Oct 9, 2026 8:30am